Close
ACHEMA MIDDLE EAST 2026

ADB to support strained pharma supply chains in fight against COVID-19

The Asian Development Bank (ADB) will make available $200 million through its Supply Chain Finance Program for companies manufacturing and distributing medicines and other...

COVID-19: big pharma confident on supply chain integrity

As the novel coronavirus continues to spread across countries, concern about the potential for disruption to the manufacture and distribution of pharmaceutical products has...

GenSight Biologics announces presentation of bilateral visual recovery from GS010 Phase III trials

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and...

Regeneron and Sanofi Aim a Rheumatoid Arthritis Drug at Coronavirus

Could an arthritis medication show promise as a treatment for the symptoms related to the coronavirus? That’s what Regeneron and Sanofi intend to find...

New Multi-Instrument Calibrator Designed to Improve Accuracy and Save Time for Leak Detection and Repair Compliance

For refineries and petrochemical plants, a new multi-instrument calibrator is designed to save time and improve accuracy of daily calibrations and drift assessments with...

WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that...

Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement

Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO)...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...